Japan’s Ministry of Health has approved new indications for KEYTRUDA (pembrolizumab) in treating certain lung and urothelial cancers. KEYTRUDA,...

A groundbreaking medical study, the SuperSaturated Oxygen Comprehensive Observational REgistry (SSCORE), has commenced with enrolling its first patient. This...

TriSalus Life Sciences‘ Pressure Enabled Drug Delivery (PEDD) method enhances the delivery of glass microspheres into liver tumors in...

LEO Pharma has announced the acceptance of its New Drug Application (NDA) by the U.S. Food and Drug Administration...

A positive efficacy, safety, and tolerability profile has emerged from Medincell and Teva’s Phase 3 SOLARIS trial evaluating Olanzapine...

Ultherapy PRIME, a groundbreaking ultrasound technology, significantly advances noninvasive skin treatments. With real-time imaging, it delivers personalized and long-lasting...

The Virtual Clinical Trials (VCT) market has surged to an estimated USD 2.64 billion in 2023, projected to reach...

This is an AI-Generated podcast. This podcast discusses the FDA’s recent guidance on inclusion and diversity in clinical trials...

Today, we had the privilege of sitting with Mumbi Kairu from The Pamoja Research Institute in Anaheim, California. Mumbi...

This is an AI-Generated podcast. The pharmaceutical industry, often viewed as a pillar of global innovation, is facing a...